OBJECTIVES: The aim was to analyse risk of relapse phenotype recurrence in multiple sclerosis and to characterise the effect of demographic and clinical features on this phenotype. METHODS: Information about relapses was collected using MSBase, an international observational registry. Associations between relapse phenotypes and history of similar relapses or patient characteristics were tested with multivariable logistic regression models. Tendency of relapse phenotypes to recur sequentially was assessed with principal component analysis. RESULTS: Among 14,969 eligible patients (89,949 patient-years), 49,279 phenotypically characterised relapses were recorded. Visual and brainstem relapses occurred more frequently in early disease and in younger patients. Sensory relapses were more frequent in early or non-progressive disease. Pyramidal, sphincter and cerebellar relapses were more common in older patients and in progressive disease. Women presented more often with sensory or visual symptoms. Men were more prone to pyramidal, brainstem and cerebellar relapses. Importantly, relapse phenotype was predicted by the phenotypes of previous relapses. (OR = 1.8-5, p = 10(-14)). Sensory, visual and brainstem relapses showed better recovery than other relapse phenotypes. Relapse severity increased and the ability to recover decreased with age or more advanced disease. CONCLUSION: Relapse phenotype was associated with demographic and clinical characteristics, with phenotypic recurrence significantly more common than expected by chance.
Hirst C., Ingram G., Pearson O., Pickersgill T., Scolding N., Robertson N., Contribution of relapses to disability in multiple sclerosis, 10.1007/s00415-008-0743-8
Lublin F. D., Baier M., Cutter G., Effect of relapses on development of residual deficit in multiple sclerosis, 10.1212/01.wnl.0000096175.39831.21
Scalfari Antonio, Neuhaus Anneke, Degenhardt Alexandra, Rice George P., Muraro Paolo A., Daumer Martin, Ebers George C., The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability, 10.1093/brain/awq118
Kalincik Tomas, Vaneckova Manuela, Tyblova Michaela, Krasensky Jan, Seidl Zdenek, Havrdova Eva, Horakova Dana, Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study, 10.1371/journal.pone.0050101
Lhermitte F, Z Neurol, 205, 47 (1973)
Mowry E M, Deen S, Malikova I, Pelletier J, Bacchetti P, Waubant E, The onset location of multiple sclerosis predicts the location of subsequent relapses, 10.1136/jnnp.2008.157305
Butzkueven H, Chapman J, Cristiano E, Grand’Maison F, Hoffmann M, Izquierdo G, Jolley D, Kappos L, Leist T, Pöhlau D, Rivera V, Trojano M, Verheul F, Malkowski J-P, MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis, 10.1177/1352458506070775
Kalincik Tomas, Spelman Timothy, Trojano Maria, Duquette Pierre, Izquierdo Guillermo, Grammond Pierre, Lugaresi Alessandra, Hupperts Raymond, Cristiano Edgardo, Van Pesch Vincent, Grand’Maison Francois, La Spitaleri Daniele, Rio Maria Edite, Flechter Sholmo, Oreja-Guevara Celia, Giuliani Giorgio, Savino Aldo, Amato Maria Pia, Petersen Thor, Fernandez-Bolanos Ricardo, Bergamaschi Roberto, Iuliano Gerardo, Boz Cavit, Lechner-Scott Jeannette, Deri Norma, Gray Orla, Verheul Freek, Fiol Marcela, Barnett Michael, van Munster Erik, Santiago Vetere, Moore Fraser, Slee Mark, Saladino Maria Laura, Alroughani Raed, Shaw Cameron, Kasa Krisztian, Petkovska-Boskova Tatjana, Braber-Moerland Leontien den, Chapman Joab, Skromne Eli, Herbert Joseph, Poehlau Dieter, Needham Merrilee, Bacile Elizabeth Alejandra Bacile, Arruda Walter Oleschko, Paine Mark, Singhal Bhim, Vucic Steve, Cabrera-Gomez Jose Antonio, Butzkueven Helmut, , Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis, 10.1371/journal.pone.0063480
McDonald W. Ian, Compston Alistair, Edan Gilles, Goodkin Donald, Hartung Hans-Peter, Lublin Fred D., McFarland Henry F., Paty Donald W., Polman Chris H., Reingold Stephen C., Sandberg-Wollheim Magnhild, Sibley William, Thompson Alan, Van Den Noort Stanley, Weinshenker Brian Y., Wolinsky Jerry S., Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis, 10.1002/ana.1032
Kurtzke J. F., Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS), 10.1212/wnl.33.11.1444
Horakova D., Kalincik T., Dolezal O., Krasensky J., Vaneckova M., Seidl Z., Havrdova E., Early predictors of non-response to interferon in multiple sclerosis, 10.1111/j.1600-0404.2012.01662.x
Deen S, Bacchetti P, High A, Waubant E, Predictors of the location of multiple sclerosis relapse, 10.1136/jnnp.2007.136440
Greer Judith M., Csurhes Peter A., Muller Diane M., Pender Michael P., Correlation of Blood T Cell and Antibody Reactivity to Myelin Proteins with HLA Type and Lesion Localization in Multiple Sclerosis, 10.4049/jimmunol.180.9.6402
Gourraud Pierre-Antoine, Sdika Michael, Khankhanian Pouya, Henry Roland G., Beheshtian Azadeh, Matthews Paul M., Hauser Stephen L., Oksenberg Jorge R., Pelletier Daniel, Baranzini Sergio E., A genome-wide association study of brain lesion distribution in multiple sclerosis, 10.1093/brain/aws363
Mowry Ellen M., Carey Robert F., Blasco Maria R., Pelletier Jean, Duquette Pierre, Villoslada Pablo, Malikova Irina, Roger Elaine, Kinkel R. Phillip, McDonald Jamie, Bacchetti Peter, Waubant Emmanuelle, Association of Multiple Sclerosis Susceptibility Variants and Early Attack Location in the CNS, 10.1371/journal.pone.0075565
Bramow Stephan, Frischer Josa M., Lassmann Hans, Koch-Henriksen Nils, Lucchinetti Claudia F., Sørensen Per S., Laursen Henning, Demyelination versus remyelination in progressive multiple sclerosis, 10.1093/brain/awq250
Prineas John W., Barnard Robin O., Revesz Tamas, Kwon Eunice E., Sharer Leroy, Cho Eun-Sock, Multiple sclerosis : Pathology of recurrent lesions, 10.1093/brain/116.3.681
Bennetto L, Burrow J, Sakai H, Cobby J, Robertson NP, Scolding N, The relationship between relapse, impairment and disability in multiple sclerosis, 10.1177/1352458511407368
Cossburn M, Ingram G, Hirst C, Ben-Shlomo Y, Pickersgill TP, Robertson NP, Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis, 10.1177/1352458511417479
Fay Alex J, Mowry Ellen M, Strober Jonathan, Waubant Emmanuelle, Relapse severity and recovery in early pediatric multiple sclerosis, 10.1177/1352458511431725
Kalincik Tomas, Vivek Vino, Jokubaitis Vilija, Lechner-Scott Jeannette, Trojano Maria, Izquierdo Guillermo, Lugaresi Alessandra, Grand’Maison Francois, Hupperts Raymond, Oreja-Guevara Celia, Bergamaschi Roberto, Iuliano Gerardo, Alroughani Raed, Van Pesch Vincent, Amato Maria Pia, Slee Mark, Verheul Freek, Fernandez-Bolanos Ricardo, Fiol Marcela, Spitaleri Daniele La, Cristiano Edgardo, Gray Orla, Cabrera-Gomez Jose Antonio, Shaygannejad Vahid, Herbert Joseph, Vucic Steve, Needham Merilee, Petkovska-Boskova Tatjana, Sirbu Carmen-Adella, Duquette Pierre, Girard Marc, Grammond Pierre, Boz Cavit, Giuliani Giorgio, Rio Maria Edite, Barnett Michael, Flechter Shlomo, Moore Fraser, Singhal Bhim, Bacile Elizabeth Alejandra, Saladino Maria Laura, Shaw Cameron, Skromne Eli, Poehlau Dieter, Vella Norbert, Spelman Timothy, Liew Danny, Kilpatrick Trevor J., Butzkueven Helmut, Sex as a determinant of relapse incidence and progressive course of multiple sclerosis, 10.1093/brain/awt281
Tremlett H, Zhao Y, Joseph J, Devonshire V, , Relapses in multiple sclerosis are age- and time-dependent, 10.1136/jnnp.2008.145805
Goodin Douglas S, Traboulsee Anthony, Knappertz Volker, Reder Anthony T, Li David, Langdon Dawn, Wolf Christian, Beckmann Karola, Konieczny Andreas, Ebers George C, , Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis, 10.1136/jnnp-2011-301178
Tremlett H., Yousefi M., Devonshire V., Rieckmann P., Zhao Y., , Impact of multiple sclerosis relapses on progression diminishes with time, 10.1212/wnl.0b013e3181c1e44f
Confavreux C., Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process, 10.1093/brain/awg081
Leray E., Yaouanq J., Le Page E., Coustans M., Laplaud D., Oger J., Edan G., Evidence for a two-stage disability progression in multiple sclerosis, 10.1093/brain/awq076
West T., Wyatt M., High A., Bostrom A., Waubant E., Are initial demyelinating event recovery and time to second event under differential control?, 10.1212/01.wnl.0000234031.30756.a0
Amato Maria Pia, Ponziani Giuseppina, Bartolozzi Maria Letizia, Siracusa Gianfranco, A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials, 10.1016/s0022-510x(99)00143-4
Runmarker Björn, Andersen Oluf, Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up, 10.1093/brain/116.1.117
Mowry E. M., Pesic M., Grimes B., Deen S., Bacchetti P., Waubant E., Demyelinating events in early multiple sclerosis have inherent severity and recovery, 10.1212/01.wnl.0000342458.39625.91
Cohen Jeffrey A, Coles Alasdair J, Arnold Douglas L, Confavreux Christian, Fox Edward J, Hartung Hans-Peter, Havrdova Eva, Selmaj Krzysztof W, Weiner Howard L, Fisher Elizabeth, Brinar Vesna V, Giovannoni Gavin, Stojanovic Miroslav, Ertik Bella I, Lake Stephen L, Margolin David H, Panzara Michael A, Compston D Alastair S, Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial, 10.1016/s0140-6736(12)61769-3
Lublin Fred D., Cofield Stacey S., Cutter Gary R., Conwit Robin, Narayana Ponnada A., Nelson Flavia, Salter Amber R., Gustafson Tarah, Wolinsky Jerry S., , Randomized study combining interferon and glatiramer acetate in multiple sclerosis : The CombiRx Study, 10.1002/ana.23863
Campbell Z., Sahm D., Donohue K., Jamison J., Davis M., Pellicano C., Auh S., Ohayon J., Frank J. A., Richert N., Bagnato F., Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis, 10.1212/wnl.0b013e3182553bd2
Bibliographic reference
Kalincik, Tomas ; Buzzard, Katherine ; Jokubaitis, Vilija ; Trojano, Maria ; Duquette, Pierre ; et. al. Risk of relapse phenotype recurrence in multiple sclerosis. In: Multiple Sclerosis : clinical and laboratory research, Vol. 20, no.11, p. 1511-1522 (2014)
